Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

被引：1

作者：

Logothetis, Christopher J. ^{[1
]}

Siefker-Radtke, Arlene ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Unit 1374, Dept Genitourinary Med Oncol, Houston, TX 77230 USA

来源：

EUROPEAN UROLOGY | 2010年 / 57卷 / 04期

关键词：

D O I：

10.1016/j.eururo.2010.01.029

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：728 / 729

页数：3

共 50 条

[21] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
Nong Xu
Xiao Chen Zhang
Jian Ping Xiong
Wei Jia Fang
Lan Fang Yu
Jiong Qian
Ling Zhang
BMC Cancer, 7
[22] Gemcitabine and paclitaxel regimen for patients with advanced transitional cell carcinoma
Takahashi, T
Higashi, S
Nishiyama, H
Itoh, N
Yamamoto, S
Kamoto, T
Ogawa, O
JOURNAL OF UROLOGY, 2005, 173 (04): : 359 - 360
[23] A phase II trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine (IAG), followed by cisplatin, gemcitabine and ifosfamide (CGI) in locally advanced urothelial cancer (UC): Final results from the M. D. Anderson Cancer Center
Siefker-Radtke, A. O.
Millikan, R. E.
Kamat, A. M.
Shen, Y.
Williams, D. L.
Grossman, H. B.
Dinney, C. P.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[24] CISPLATIN, METHOTREXATE AND VINBLASTINE PLUS SURGICAL RESTAGING FOR PATIENTS WITH ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM
MILLER, RS
FREIHA, FS
REESE, JH
OZEN, H
TORTI, FM
JOURNAL OF UROLOGY, 1993, 150 (01): : 65 - 69
[25] Fluoropyrimidines plus Cisplatin versus Gemcitabine/Gemcitabine plus Cisplatin in Locally Advanced and Metastatic Biliary Tract Carcinoma - A Retrospective Study
Croitoru, Adina
Gramaticu, Julia
Dinu, Ioana
Gheorghe, Liana
Alexandrescu, Sorin
Buica, Florina
Luca, Ioana
Becheanu, Gabriel
Herlea, Vlad
Simionov, Iulia
Hrehoret, Doina
Lupescu, Ioana
Popescu, Irinel
Diculescu, Mircea
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2012, 21 (03) : 277 - 284
[26] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
Clark, PE
Stindt, D
Hall, MC
Harmon, M
Lovato, JF
Mohler, R
Kimbrough, C
Torti, FM
JOURNAL OF UROLOGY, 2005, 173 (04): : 360 - 360
[27] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
Clark, PE
Stindt, D
Hall, MC
Harmon, M
Lovato, JF
Mohler, R
Kimbrough, C
Torti, FM
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 409S - 409S
[28] Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract
Galsky, Matthew D.
Iasonos, Alexia
Mironov, Svetlana
Scattergood, Joseph
Donat, S. Machele
Bochner, Bernard H.
Herr, Harry W.
Russo, Paul
Boyle, Mary G.
Bajorin, Dean F.
UROLOGY, 2007, 69 (02) : 255 - 259
[29] Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer
Niedersuess-Beke, Dora
Puntus, Thomas
Kunit, Thomas
Gruenberger, Birgit
Lamche, Michael
Loidl, Wolfgang
Bohm, Reinhard
Kraischits, Nicole
Kudlacek, Stefan
Schramek, Paul
Meran, Johannes G.
ONCOLOGY, 2017, 93 (01) : 36 - 42
[30] Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy
Kaya, Ali O.
Coskun, Ugur
Ozkan, Metin
Sevinc, Alper
Yilmaz, Ahmet U.
Gumus, Mahmut
Unal, Olcun U.
Ozdemir, Nuriye Y.
Alici, Suleyman
Berk, Veli
Degerli, Hatice
Oner, Mehmet K.
Ozturk, Cemil
Kefeli, Umut
Camci, Celalettin
ONKOLOGIE, 2012, 35 (10): : 576 - 580

← 1 2 3 4 5 →